Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Article
  • Published:

Prostate-specific expression of Bax delivered by an adenoviral vector induces apoptosis in LNCaP prostate cancer cells

Gene Therapy volume 8, pages 1363–1371 (2001)Cite this article

Abstract

In prostate carcinoma, overexpression of the anti-apoptotic gene Bcl-2 has been found to be associated with resistance to therapies including radiation and androgen ablation. Restoring the balance of Bcl-2 family members may result in the induction of apoptosis in prostate cancer cells previously resistant to treatment. To accomplish this, a strategy involving overexpression of the pro-apoptotic gene Bax was executed. The use of cytotoxic genes such as Bax require selective expression of the gene. In this study, we examined the ability of selective expression of Bax protein directed by a prostate-specific promoter to induce apoptosis in human prostate carcinoma. A second-generation adenoviral vector was constructed with the modified prostate-specific probasin promoter, ARR2PB, directing expression of an HA-tagged Bax gene and a green fluorescent protein reporter translated from an internal ribosome entry site (ARR2PB.Bax.GFP). ARR2PB promoter activity is tightly regulated and highly prostate specific and is responsive to androgens and glucocorticoids. The prostate-specific promoter-Bax-GFP transgene cassette was inserted into a cloning site near the right inverted terminal repeat of the adenoviral vector to retain specificity of the promoter. LNCaP cells infected with Ad/ARR2PB.Bax.GFP showed high levels of Bax expression 48 h after infection resulting in an 85% reduction in cell viability. Importantly, LNCaP cells stably transfected to overexpress Bcl-2 showed similar patterns of cell death when infected with Ad/ARR2PB.Bax.GFP, an 82% reduction in cell viability seen 48 h after infection. Apoptosis was confirmed by measuring caspase activation and using the TUNEL assay. Tissue specificity was evaluated using A549 cells (lung adenocarcinoma), SK-Hep-1 (liver cancer) cells, and Hela (cervical cancer) cells which did not show detectable expression of virally delivered Bax protein or any increase in cell death. Systemic administration of Ad/ARR2PB. Bax.GFP in nude mice revealed no toxicity in liver, lung, kidney, or spleen. This study shows that infection with the second-generation adenovirus, ARR2PB.Bax.GFP, results in highly specific cytotoxicity in LNCaP cells, and that consequent overexpression of Bax in prostate carcinoma, even in the context of high levels of Bcl-2 protein, resulted in apoptosis. These results suggest that a second-generation adenovirus-mediated, prostate-specific Bax gene therapy is a promising approach for the treatment of prostate cancer. Gene Therapy (2001) 8, 1363–1371.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  1. Brady H, Gil-Gomez G . Molecules in focus. Bax. The pro-apoptotic Bcl-2 family member, Bax Int J Biochem Cell Biol 1998 30: 647–650

    Article  CAS  PubMed  Google Scholar 

  2. Marcelli M et al. Heterogeneous apoptotic responses of prostate cancer cell lines identify an association between sensitivity to staurosporine-induced apoptosis, expression of Bcl-2 family members, and caspase activation Prostate 2000 42: 260–273

    Article  CAS  PubMed  Google Scholar 

  3. van Brussel JP et al. Chemosensitivity of prostate cancer cell lines and expression of multidrug resistance-related proteins Eur J Cancer 1999 35: 664–671

    Article  CAS  PubMed  Google Scholar 

  4. Srivastava RK, Sasaki CY, Hardwick JM, Longo DL . Bcl-2-mediated drug resistance: inhibition of apoptosis by blocking nuclear factor of activated T lymphocytes (NFAT)-induced Fas ligand transcription J Exp Med 1999 190: 253–265

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Ikawa S, Obinata M, Ikawa, Y . Human p53-p51 (p53-related) fusion protein: a potent BAX transactivator Jpn J Cancer Res 1999 90: 596–599

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Pearson AS et al. Up-regulation of the prospoptotic mediators Bax and Bak after adenovirus-mediated p53 gene transfer in lung cancer cells Clin Cancer Res 2000 6: 887–890

    CAS  PubMed  Google Scholar 

  7. Xiang J et al. Pro-apoptotic treatment with an adenovirus encoding Bax enhances the effect of chemotherapy in ovarian cancer J Gene Med 2000 2: 97–106

    Article  CAS  PubMed  Google Scholar 

  8. Yagi et al. Proapoptotic gene BAX is frequently mutated in hereditary nonpolyposis colorectal cancers but not in adenomas Gastroenterology 1998 114: 268–274

    Article  CAS  PubMed  Google Scholar 

  9. Ouyang H et al. The BAX gene, the promoter of apoptosis, is mutated in genetically unstable cancers of the colorectum, stomach, and endometrium Clin Cancer Res 1998 4: 1071–1074

    CAS  PubMed  Google Scholar 

  10. Gjertsen BT, Logothetis CJ, McDonnell TJ . Molecular regulation of cell death and therapeutic strategies for cell death instruction in prostate carcinoma Cancer Metastasis Rev 1999 17: 345–351

    Article  CAS  Google Scholar 

  11. Adams JM, Cory S . The Bcl-2 protein family: arbiters of cell survival Science 1998 281: 1322–1326

    Article  CAS  PubMed  Google Scholar 

  12. Arafat W et al. An adenovirus encoding proapoptotic Bax induces apoptosis and enhances the radiation effect in human ovarian cancer Mol Ther 2000 1: 545–554

    Article  CAS  PubMed  Google Scholar 

  13. Sakakura C et al. Overexpression of bax sensitizes human breast cancer MCF-7 cells to radiation-induced apoptosis Int J Cancer 1996 67: 101–105

    Article  CAS  PubMed  Google Scholar 

  14. Kagawa S et al. A binary adenoviral vector system for expressing high levels of the proapoptotic gene bax Gene Therapy 2000 7: 75–79

    Article  CAS  PubMed  Google Scholar 

  15. Coll J-L et al. Antitumor activity of bax and p53 naked gene transfer in lung cancer: in vitro and in vivo analysis Hum Gene Ther 1998 9: 2063–2074

    Article  CAS  PubMed  Google Scholar 

  16. Komatsu K et al. Cre-loxP-mediated bax gene activation reduces growth rate and increases sensitivity to chemotherapeutic agents in human gastric cancer cells Cancer Gene Ther 2000 7: 885–892

    Article  CAS  PubMed  Google Scholar 

  17. Rosse T et al. Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c Nature 1998 391: 496–499

    Article  CAS  PubMed  Google Scholar 

  18. Rubinchik S et al. Adenoviral vector which delivers FasL-GFP fusion protein regulated by the tet-inducible expression system Gene Therapy 2000 7: 875–885

    Article  CAS  PubMed  Google Scholar 

  19. Tai Y-T, Strobel T, Kufe D, Cannistra SA . In vivo cytotoxicity of ovarian cancer cells through tumor-selective expression of the BAX gene Cancer Res 1999 59: 2121–2126

    CAS  PubMed  Google Scholar 

  20. Rubinchik S et al. Creation of a new transgene cloning site near the right ITR of Ad5 results in reduced enhancer interference with tissue-specific and regulatable promoters Gene Therapy 2001 8: 247–253

    Article  CAS  PubMed  Google Scholar 

  21. Imler J-L et al. Targeting cell-specific gene expression with an adenovirus vector containing the lacZ gene under the control of the CFTR promoter Gene Therapy 1996 3: 49–58

    CAS  PubMed  Google Scholar 

  22. Shi Q, Wang Y, Worton R . Modulation of the specificity and activity of a cellular promoter in an adenoviral vector Hum Gene Ther 1997 8: 403–410

    Article  CAS  PubMed  Google Scholar 

  23. Zhang J, Thomas T, Kasper S, Matusik R . A small composite probasin promoter confers high levels of prostate-specific gene expression through regulation by androgens and glucocorticoids in vitro and in vivo Endocrinology 2000 141: 4698–4710

    Article  CAS  PubMed  Google Scholar 

  24. Mizuguchi H et al. IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector Mol Ther 2000 1: 376–382

    Article  CAS  PubMed  Google Scholar 

  25. Jo M et al. Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand Nat Med 2000 6: 564–567

    Article  CAS  PubMed  Google Scholar 

  26. Murphy AL . Apoptin: nuclear switch triggers cancer cell death Gene Therapy 1999 6: 713–714

    Article  CAS  PubMed  Google Scholar 

  27. Clarke MF et al. A recombinant bcl-XS adenovirus selectively induces apoptosis in cancer cells but not in normal bone marrow cells Proc Natl Acad Sci USA 1995 92: 11024–11028

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Yamabe K et al. Cancer gene therapy using a pro-apoptotic gene, caspase-3 Gene Therapy 1999 6: 1952–1959

    Article  CAS  PubMed  Google Scholar 

  29. Dong Y-B et al. Adenovirus-mediated E2F-1 gene transfer efficiently induces apoptosis in melanoma cells Cancer 1999 86: 2021–2033

    Article  CAS  PubMed  Google Scholar 

  30. Ji L et al. Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression Cancer Res 1999 59: 3333–3339

    CAS  PubMed  Google Scholar 

  31. Kataoka M et al. Down-regulation of bcl-2 is associated with p16INK4-mediated apoptosis in non-small cell lung cancer cells Oncogene 2000 19: 1589–1595

    Article  CAS  PubMed  Google Scholar 

  32. Reed JC, Jurgensmeier JM, Matsuyama S . Bcl-2 family proteins and mitochondria Biochim Biophys Acta 1998 1366: 127–137

    Article  CAS  PubMed  Google Scholar 

  33. Green DR, Reed JC . Mitochondria and apoptosis Science 1998 281: 1309–1312

    Article  CAS  PubMed  Google Scholar 

  34. Xiang J, Chao DT, Korsmeyer SJ . BAX-induced cell death may not require interleukin 1β-converting enzyme-like proteases Proc Natl Acad Sci USA 1996 93: 14559–14563

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Marzo I et al. Bax adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis Science 1998 281: 2027–2031

    Article  CAS  PubMed  Google Scholar 

  36. Zamzami N et al. Subcellular and submitochondrial mode of action of Bcl-2-like oncoproteins Oncogene 1998 16: 2265–2282

    Article  CAS  PubMed  Google Scholar 

  37. Shinoura N et al. Relative level of expression of Bax and Bcl-XL determines the celular fate of apoptosis/necrosis induced by the overexpression of Bax Oncogene 1999 18: 5703–5713

    Article  CAS  PubMed  Google Scholar 

  38. Culig Z et al. Mutant androgen receptor detected in advanced stage prostatic carcinoma is activated by adrenal androgens and progesterone Mol Endocrinol 1993 12: 1541–1550

    Google Scholar 

  39. Gleave M, Bruchovsky N, Goldenberg SL, Rennie P . Intermittent androgen suppression for prostate cancer: rationale and clinical experience Eur Urol 1998 34 (Suppl. 3): 37–41

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Dr Robert J Matusik for the ARR2PB promoter. We thank Janie Nelson for secretarial assistance in preparation of this manuscript. This work was supported by NCI CA69596 to JSN.

Author information

Authors and Affiliations

  1. Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC, USA

    SL Lowe, S Rubinchik, J-Y Dong & JS Norris

  2. Department of Molecular Pathology, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA

    T Honda & TJ McDonnell

Authors
  1. SL Lowe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S Rubinchik
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T Honda
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. TJ McDonnell
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J-Y Dong
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. JS Norris
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lowe, S., Rubinchik, S., Honda, T. et al. Prostate-specific expression of Bax delivered by an adenoviral vector induces apoptosis in LNCaP prostate cancer cells. Gene Ther 8, 1363–1371 (2001). https://doi.org/10.1038/sj.gt.3301531

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3301531

Keywords

This article is cited by

Search

Advanced search

Quick links